The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...

Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay ...

Cells sitting side by side in the same tissues are not identical. Each cell carries its own subtly different chemical ...

A paper published in the journal Biomarker Research by a cross-university team led by Queen Mary University of London ...

Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

Periodontal (gum) disease is one of the most prevalent diseases worldwide, caused by the bacterium Porphyromonas gingivalis ...

AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...